COMMUNIQUÉS West-GlobeNewswire

RavenQuest Provides Corporate Update
26/06/2019
VANCOUVER, British Columbia, June 26, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) is pleased to provide the following full update on all [...]
Change in the Terveystalo Plc Executive team: Johanna Karppi, SVP of HR to leave the company
26/06/2019
Terveystalo Plc. Stock Exchange Release 26 June 2019 at 12:00 EEST Johanna Karppi, Senior Vice President, HR, has decided to leave Terveystalo as of 1 October 2019 to join Finnair, Finnish airline. Terveystalo has [...]
Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome
26/06/2019
Press release – No. 16 / 2019 Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome Short bowel syndrome (SBS) is a complex [...]
Oasmia presents full-year report and status in the Board's review through audiocast on June 28
26/06/2019
Oasmia will hold an audiocast and telephone conference on Friday 28 June at 09:00 (CET) to present the company's full-year report for the financial year 2018/2019 and the status of the board's previously communicated [...]
DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer
26/06/2019
Montrouge, France, June 26, 2019 DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer Dr. Mohideen brings extensive experience in clinical drug development Dr. Hugh Sampson to [...]
DBV Technologies annonce la nomination du Docteur Pharis Mohideen au poste de Directeur Médical
26/06/2019
Montrouge, France, le 26 juin (7 h 30 CEST) 2019 DBV Technologies annonce la nomination du Docteur Pharis Mohideen au poste de Directeur Médical Le Docteur Mohideen possède une vaste expérience dans le développement [...]
Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology
26/06/2019
INNATE PHARMA ANNOUNCES PUBLICATION OF IPH4102 PHASE I CLINICAL TRIAL RESULTS FOR CTCL IN THE LANCET ONCOLOGY · Data to date demonstrate high activity and favorable safety profile in Sézary syndrome, an aggressive form [...]
Innate Pharma annonce la publication des résultats de l’essai de Phase I d’IPH4102 dans les LTC dans The Lancet Oncology
26/06/2019
INNATE PHARMA ANNONCE LA PUBLICATION DES RÉSULTATS DE L’ESSAI DE PHASE I D’IPH4102 DANS LES LTC DANS THE LANCET ONCOLOGY · Les données à ce jour font état d’un niveau d’activité élevé ainsi que d’un profil de tolérance [...]
Helsinn appoints Giorgio Calderari, Group General Manager and Chief Operating Officer, to the Board of Directors
26/06/2019
Helsinn appoints Giorgio Calderari, Group General Manager and Chief Operating Officer, to the Board of Directors Lugano, Switzerland, June 26, 2019: Helsinn, the Swiss pharmaceutical group focused on building quality [...]
Cambium Networks Corporation Announces Pricing of Initial Public Offering
26/06/2019
ROLLING MEADOWS, Ill., June 25, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”), a provider of wireless broadband networking infrastructure solutions, today announced the pricing of its initial public [...]
Wildflower Announces Closing of Private Placement
26/06/2019
Not for distribution to U.S. newswire services or for dissemination in the U.S. VANCOUVER, British Columbia, June 25, 2019 (GLOBE NEWSWIRE) -- via NetworkWire: Wildflower Brands Inc. (CSE: SUN) (the “Company”) announces [...]
ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
25/06/2019
Amsterdam, The Netherlands – 25 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that the negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM, “PBKM”) regarding the proposed sale of [...]
AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results
25/06/2019
Announces name change to Beyond Air™ Completed uplisting to the NASDAQ and $7.96 million PIPE financing Anticipate PMA submission in the third quarter of calendar 2019 Anticipate CE Mark in the first half of calendar [...]
Medtronic Announces the Upsizing of its Maximum Tender Offer to up to $4.35 billion for Certain Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.
25/06/2019
DUBLIN, June 25, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously announced cash tender offer (the “Maximum Tender Offer”) by its wholly-owned indirect [...]
Medtronic Announces Pricing of €5 Billion of Senior Notes
25/06/2019
DUBLIN, June 25, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. (“Medtronic Luxco”), has priced an offering (the “Offering”) of €250, [...]
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
25/06/2019
BILLERICA, Mass., June 25, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
25/06/2019
SOUTH SAN FRANCISCO, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/06/2019
SOUTH SAN FRANCISCO, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit
25/06/2019
SAN FRANCISCO, June 25, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]

Pages